Brief: AnaptysBio Q4 Net Income USD 49.614 Million
03/03/2026 21:15
Mar 03 (Reuters) - AnaptysBio Q4 collaboration revenue USD 108.249 million. Q4 operating expenses USD 41.348 million Q4 income from operations USD 66.901 million
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged